• Repurposing Novobiocin: In Vitro Activity Against SFTSV

  2026-05-13

  This article examines the recent in vitro evaluation of Novobiocin, an aminocoumarin antibiotic, and other FDA-approved drugs for antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV). The study identifies Novobiocin as a promising antiviral compound, offering new avenues for antiviral and antibacterial resistance research.

• 40-Hz Light Flicker Regulates Retinal Microglia for Amyloid

  2026-05-13

  This study demonstrates that 40-Hz light flicker enhances retinal amyloid-β clearance in aged mice by upregulating MHC-II+ microglia activity. The findings highlight a non-invasive strategy for promoting metabolic waste removal in age-related retinal disorders and establish a mechanistic link between flicker stimulation and immune modulation.

• RG108 (A1913): Practical Insights for Epigenetic Modulation

  2026-05-12

  This article provides an evidence-based exploration of RG108 (SKU A1913), a DNA methyltransferase inhibitor, guiding biomedical researchers through real-world experimental challenges in cell-based assays. It distills validated workflows, protocol considerations, and vendor reliability, emphasizing reproducibility and practical advantages of using RG108 from APExBIO.

• Simvastatin (Zocor): Applied Workflows in Lipid and Cancer R

  2026-05-12

  Simvastatin (Zocor) is a gold-standard tool for dissecting cholesterol biosynthesis and apoptosis induction in hepatic cancer models. This article delivers scenario-based protocols, advanced troubleshooting, and insights into leveraging high-content phenotypic profiling for robust, reproducible results using APExBIO’s research-grade compound.

• Filipin III (SKU B6034): Optimizing Cholesterol Detection Wo

  2026-05-11

  This article addresses real-world laboratory challenges in cholesterol detection and membrane analysis, focusing on how Filipin III (SKU B6034) delivers robust, reproducible performance for cell biology assays. Drawing on current literature and validated protocols, it guides researchers in leveraging Filipin III for sensitive, quantitative membrane cholesterol visualization while ensuring workflow reliability.

• Bestatin (Ubenimex): Data-Driven Solutions for Cell Assays

  2026-05-11

  This article explores how Bestatin (Ubenimex), particularly APExBIO SKU A2575, addresses critical pain points in cell viability, apoptosis, and multidrug resistance (MDR) research. Scenario-driven Q&A blocks provide practical, evidence-based guidance, ensuring reproducible and interpretable results in complex laboratory workflows.

• Neutrophil Extracellular Traps in CML: TKI Effects and Mecha

  2026-05-10

  This study demonstrates that neutrophil extracellular trap (NET) formation is elevated in chronic myeloid leukemia (CML) and that various tyrosine kinase inhibitors (TKIs) differentially modulate this process. The findings reveal a potential mechanistic link between TKI therapy, NETs, and vascular toxicity, providing new perspectives for CML pathogenesis and therapeutic evaluation.

• Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Neuroplas

  2026-05-09

  Baicalin, a flavone glycoside from Scutellaria baicalensis, offers unique advantages for modulating neuroplasticity and cancer signaling, with reproducible outcomes in amblyopia and oncology models. APExBIO’s high-purity Baicalin enables advanced experimental designs by ensuring reliable pathway modulation and validated bioactivity.

• H-89 in Osteoblast Research: Precision Tools for cAMP Pathwa

  2026-05-08

  Explore how H-89, a potent cAMP-dependent protein kinase inhibitor, enables advanced dissection of cAMP signaling and metabolic rewiring in osteoblastogenesis. This article offers unique protocol insights and practical guidance for metabolic and bone research.

• Novobiocin: Aminocoumarin Antibiotic for Antimicrobial Workf

  2026-05-08

  Novobiocin enables potent antibacterial, antiparasitic, and antiviral workflows by uniquely targeting bacterial DNA gyrase and Hsp90. This guide translates its dual mechanism and protocol flexibility into reproducible, high-impact experimental strategies, with actionable troubleshooting tips for resistance and advanced phenotypic assays.

• Dye Models Enhance Small Biopsy Detection: Evidence from Pat

  2026-05-07

  This study systematically evaluated the effectiveness of various tissue marking dyes, including merbromin, hematoxylin, eosin, crystal violet, and alcian blue, for improving the visualization and retention of small tissue biopsies during histopathological processing. The findings underscore hematoxylin’s superior balance of visibility and diagnostic non-interference, informing best practices for pre-analytical tissue management.

• Anti-Inflammatory Anti-Angiogenic Stents Combat Tracheal Res

  2026-05-07

  Zhao et al. introduce a dual-action airway stent integrating anti-inflammatory and anti-angiogenic agents to address tracheal in-stent restenosis (TISR). Through advanced electrospinning, the study demonstrates suppression of fibrosis, angiogenesis, and infection, offering translational promise for airway management.

• LLY507 (SKU B6119): Reliable SMYD2 Inhibition in Cancer Rese

  2026-05-06

  LLY507 (SKU B6119) is a highly selective and potent SMYD2 inhibitor, designed to address key challenges in cell viability, proliferation, and cytotoxicity assays. This article provides scenario-driven guidance for optimizing experimental reproducibility and sensitivity using LLY507, with evidence-backed insights tailored to biomedical researchers and lab technicians.

• Early Pheromone Perception Drives Neurodegeneration in C. el

  2026-05-06

  Peng et al. (2023) reveal how early-life exposure to specific pheromones remodels neural development and accelerates adult neurodegeneration in C. elegans. This work elucidates a mechanistic link between environmental chemical cues, altered neurodevelopmental signaling, and the inhibition of neuronal autophagy, with implications for understanding proteostasis and neurodegenerative disease origins.

• Bestatin (Ubenimex): Precision Workflows in MDR & Cancer Res

  2026-05-05

  Bestatin (Ubenimex) is a benchmark aminopeptidase inhibitor, enabling reliable dissection of multidrug resistance and apoptosis pathways with nanomolar precision. This guide synthesizes best practices, troubleshooting insights, and advanced use-cases, drawing from the latest cancer research and APExBIO's trusted formulations.

15130 records 1/1009 page Next 12345 下5页 Last page